Chronic lymphocytic leukemia cells, representing a clonal population of resting B lymphocytes, were induced to differentiate into immunoglobulin-secreting lymphoblasts and plasmablasts by phorbol 12-myristate 13-acetate. The induction resulted in a rapid increase in the molar ratio of secreted/membrane-bound 1.-chain mRNA. Immunoglobulin secretion was preceded by a transition of the cells from the Go to G, phase of the cell cycle, as indicated by an increase in RNA and protein synthesis, and an overall increase in cellular RNA. The cells, however, became blocked in G1 and did not enter S phase. The expression of MYC and FOS was rapidly induced by the phorbol 12-myristate 13-acetate treatment. The induction ofFOS preceded the shift in secreted/membrane-bound si-chain mRNA molar ratio, while that of MYC occurred concomitantly with the shift, but prior to induction of total RNA synthesis and immunoglobulin secretion. MYC expression remained at a relatively high level during the whole differentiation process. It is thus concluded that a decline of MYC expression is not a prerequisite for differentiation of the chronic lymphocytic leukemia cells. This suggests that MYC expression may play a different role during differentiation of nonproliferating B cells than in the myelomonocytic cell lines HL-60 and U-937, where MYC expression has been reported to decrease during induced differentiation. The results also show that the expression of the MYC and FOS genes does not result in the transition of these cells into the S phase of the cell cycle.
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It has been suggested that protooncogenes have a role in the control of growth and differentiation of normal and malignant cells (1), a view which is supported by the characteristics of the protooncogenes MYC and FOS in various cell types. The expression of these two genes is rapidly induced during the Go to G1 transition by several growth factors and mitogens (2) (3) (4) (5) . Moreover, a high constitutive expression of the c-myc or v-myc genes under the influence of strong promoters has been reported to reduce the requirement for growth factors in various cell types (6) (7) (8) . These results suggest that the expression of MYC and FOS may be part of the signal pathway used by growth factors.
Normal hematopoietic cells appear to be regulated by two coupled, but inversely related, genetic programs-one for proliferation and one for differentiation-operating during the stepwise maturation process resulting in terminally differentiated cells (9) . Established malignant hematopoietic cell lines, blocked in their differentiation but capable of undergoing partial or terminal differentiation when exposed to various inducers, have been used as models for investigating the relationship between protooncogenes and differentiation. A decrease in MYC expression has been reported during induced differentiation of the human cell lines HL-60 and U-937 (10) (11) (12) . The view has, therefore, been put forward that MYC expression needs to be down-regulated to allow the differentiation program to be carried out (13) . FOS, on the other hand, is rapidly induced and, thereafter, continuously expressed after phorbol 12-myristate 13-acetate (PMA) induction of HL-60 and U-937 cells and has been suggested to be a prerequisite for macrophage differentiation (14, 15) .
Few studies have been performed concerning the relationship between the expression of MYC and FOS and human B-cell differentiation (16) . In the present study we have employed a human chronic lymphocytic leukemia (CLL), 1-73, with phenotypic features similar to those of resting normal B lymphocytes. I-73 cells may be induced by PMA to differentiate into immunoglobulin-(Ig) secreting lymphoblasts and plasmablasts without undergoing proliferation (17, 18) . Using flow cytometry to quantitate RNA, DNA, cell volume, and some cell cycle-related antigens, Nilsson et al. (19) 32P-labeled probe as described (22) . The filters were subsequently washed in 15 mM NaCl/1.5 mM sodium citrate/0.1% NaDodSO4 at 530C for 2 hr prior to autoradiography.
Autoradiograms were analyzed by densitometric scanning (Shimadzu CS-930, Kyoto, Japan).
Probes. For MYC a 1.5-kilobase (kb) EcoRI-Cla I fragment spanning the third exon of the human MYC gene, prepared from a human MYC genomic clone (23), a gift from M. Jansson and B. Vennstrom, EMBL, Heidelberg, was used. For FOS a 2.7-kb Xho I-Nco I fragment from a human FOS clone (24) , provided by R. Muller, EMBL, Heidelberg, was used. For actin a 1.2-kb Pst I fragment from a mouse a-actin cDNA clone, p91 (25) , provided by M. Buckingham, Pasteur Institute, Paris, was used. For , chains a mixture of three EcoRI fragments, each approximately 1.5 kb, from a human , chain probe, , supplied by P. Leder, Harvard Medical School, Boston, was used. The purified fragments were 32P-labeled by nick-translation (27) to a specific activity greater than 108 cpm/,ug of DNA.
35S-Labeling and Immunoprecipitation. I-73 cells were labeled with [35S]methionine (50 ,Ci/ml; specific activity, 1100 Ci/mmol; Amersham) for 3 hr. Prepared cell extracts were immunoprecipitated and analyzed by electrophoresis in NaDodSO4/polyacrylamide gels followed by autoradiography as described in detail (28) . Films were exposed for 4-6 days and scanned densitometrically. Two anti-MYC peptide antisera ("anti-c-myc N-ter I" and "anti-c-myc N-ter II") were used for the immunoprecipitation of MYC proteins from the CLL cells. Both antisera are directed against residues 24-40 of the human MYC protein as described in detail for anti-c-myc N-ter I (29) . Anti-c-myc N-ter I recognizes a relatively stable, nonphosphorylated p65 MYC protein in human cells, whereas anti-c-myc N-ter II detects a short-lived phosphorylated pp64 MYC protein in human cells (28, 29) . Anti-c-myc N-ter I was provided by H. Persson, Department of Medical Genetics, University of Uppsala, Uppsala, Sweden, and anti-c-myc N-ter II was generated and provided by T (Fig. 1 A and B) . The [3H]uridine incorporation into trichloroacetic acid-precipitable material began to increase between 4 and 12 hr after induction, yielding a 13-fold increase, peaking at 48 hr. The protein synthesis was enhanced already after 4 hr, peaking at a 25-fold higher level, between 24 and 72 hr after PMA treatment. The elevated RNA synthesis resulted in an increase in total RNA content per cell between 12 and 24 hr after induction. At 72 hr, the RNA content per cell was 3-fold higher when compared to uninduced cultures (Fig. 1B) after induction, reaching a level of 2.5 ,ug per ml after 72 hr (Fig. 1B) .
The activation of the 1-73 cells was accompanied by minimal DNA synthesis between 24 and 72 hr (Fig. 1C) A-chain mRNA expression and in vitro differentiation was studied by RNA gel blot analysis ( Fig. 2A) (25) . minimum level that was 35% of the value in uninduced cells at 4 hr. In parallel with this alteration, the molar ratio between /,. and M, mRNA changed gradually from -1:1 to 4:1. The amount of A-chain mRNA subsequently increased reaching a maximum between 12 and 24 hr (data not shown), coinciding with the initial detection of IgM secretion (Fig. 1B) , and finally approaching the control level 72 hr after induction. Actin expression increased after 12 hr, concomitantly with the blast transformation, and reached a 4.5-fold higher level compared with uninduced cells at 72 hr (Fig. 2B) .
Drastically Increased Levels of MYC mRNA After PMA Induction. To investigate whether MYC mRNA is expressed during activation and differentiation of the nonproliferative CLL cells, the same samples as above were analyzed using a human MYC-specific probe (Fig. 3A) Neither the MYC nor the FOS expression in the 1-73 cell population was significantly altered after proliferating T cells were depleted (from 5% to 0.1%), using OKT3 antibody plus two rounds of a 1:3 dilution of baby rabbit complement, demonstrating that the elevated oncogene expression indeed occurred in the B cells (data not shown).
Increased Levels of MYC Proteins After PMA Induction. As shown above, MYC expression in the CLL cells is rapidly increased after PMA stimulation, similar to the effect of mitogens or growth factors in other cell systems (2-5, 29, 30, 34) . As the 1-73 cells never enter S phase, and as MYC expression is down-regulated in other differentiating systems, it was important to rule out the possibility of a specific block in the translation of the MYC mRNA. Immunoprecipitations of [355] methionine labeled proteins at different times after induction, using the MYC protein-specific antibody anti-c-myc N-ter II (28) , showed that a 64-kDa MYC protein was present in very low amounts in uninduced 1-73 cells (Fig.  4) , increased drastically after 4 hr of PMA stimulation, and then decreased to a minimum value at 24 hr and remained constant at 72 hr after induction.
By densitometric scanning we found the stimulation at 4 hr to be "18-fold and -3-fold at 24 hr. The changes in the MYC protein levels were similar to those observed for the MYC mRNA although the degree of stimulation was less pronounced. Immunoprecipitation with another MYC-specific antibody (anti-c-myc N-ter I) (29) , detected the accumulation of a 65-kDa MYC protein in PMA-stimulated cultures, which was hardly detectable in uninduced cells (data not shown). DISCUSSION MYC gene expression has been studied in normal human lymphocytes that were induced to proliferate (29, 30, 34, 35) , but none of these studies have examined whether differentiation was simultaneously induced. However, the expression of MYC and FOS in differentiating human hematopoietic cells has been investigated using established cell lines (10) (11) (12) 16) . We chose to study the expression of these two oncogenes in the B-CLL system, which is a clonal population of resting (17) (18) (19) 36) . The results reveal that differentiation is also reflected at the mRNA level by a rapid increase in the molar ratio of A,/w, mRNA. The early transient decrease in A-chain expression after induction has also been observed in another CLL population (37) and may contribute to the transient down-regulation of surface IgM reported to occur after activation of normal B cells (38 (14) .
The present finding that B-cell differentiation may occur without the down-regulation of MYC gene expression conflicts with the hypothesis that the MYC product might prevent differentiation of many hematopoietic cell types. The latter view is supported by several studies on induced differentiation in the HL-60 and U-937 cell lines (10) (11) (12) and by theoretical assumptions based on the deregulated MYC expression in Burkitt lymphoma (13) . We, therefore, tested the possibility that the translation of the MYC RNA was defective in the I-73 cells. Immunoprecipitation, however, using MYC-specific antibodies clearly demonstrated that the MYC mRNA was translated into the expected protein products. Thus B-cell differentiation may indeed proceed without down-regulation of MYC. A similar conclusion was drawn by Benjamin et al. (16) (ii) An alternative view is that the increasedFOS and MYC expression in 1-73 may promote differentiation. The maturation of 1-73 cells to Ig secretion is preceded by a Go to G, transition during which FOS and MYC expression is induced. It is possible that MYC and FOS play a role in the regulation of some of the events that take place during this transition; i.e., the enhancement of several metabolic processes including RNA and protein synthesis, cellular enlargement and competence to respond to growth and differentiation factors (38) . This activation of the cellular machinery appears to be a prerequisite for Ig secretion. FOS and MYC expression in B cells may thus promote competence to respond not only to growth factors, as suggested for normal B cells (34) , but also to differentiation factors. Moreover, the distinction between growth and differentiation factors for B cells may be an oversimplification, since a report suggests that a single cloned factor will promote both proliferation and differentiation (39) .
